Habitus Associates Co., LTD
SEOUL, SOUTH KOREA / ACCESSWIRE / September 17, 2023 / Habitus Associates Co., LTD., the entity behind the online art platform 'Artue' and under the leadership of Bo Young SONG, has secured a seed investment of 4 billion won. This investment round was led by SoftBank Ventures Asia with several angel investors also taking part.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Artue, powered by Habitus Associates Co., LTD, is pioneering the art industry's digital transformation. The platform is revolutionizing the traditionally offline, high-barrier art brokerage, providing emerging artists with market entry opportunities and reducing purchasing barriers for collectors.
A notable feature of Artue is its digital twin technology, enabling a virtual experience that mirrors physical art spaces. With the integration of online transactional capabilities, Artue is also enhancing its digital Catalogue Raisonné service and introducing resale functionalities.
The team at Habitus Associates Co., LTD. comprises industry veterans from influential corporations like Naver, Kakao, Credit-Suisse, LG, Hyundai Motor Group, Kukje Gallery, and Korea Arts Management Service. The advisory board includes Eugene Whang, with two decades at Apple; Alan Lau, previously of Tencent and now with Animoca Brands; Changwook Kim of Naver; and Federico Tan, a communications specialist with clients including Sacai and Takashi Murakami.
With the new funds, the company intends to further develop and hone Artue's offerings, boost its technical capabilities, and expand its reach. Strategic talent acquisition and international artist promotion are also on the agenda, along with securing additional intellectual properties to diversify Artue's portfolio.
In 2022, the global art market was valued at an impressive 80 trillion won, with projections indicating continued growth driven by an increase in affluent individuals and the expanding digital landscape. Remarkably, South Korea's art market achieved over 1 trillion won in sales during the challenging pandemic year. Estimates for 2022 show potential growth to 1.377 trillion won. With Seoul witnessing a surge in global galleries and auction houses, South Korea is positioning itself as a significant player in the art market alongside giants like the US, UK, China, and Japan.
Bo Young SONG, co-founder of Habitus Associates Co., LTD., has served as a member of the Selection Committee member of Art Basel Hong Kong for a decade and as the first Asian partner and the regional CEO of renowned European art publisher Cahiers d'Art. She stated, "Artue is our response to the digital era. Beyond traditional art experiences, our platform aims to expedite and enhance the journey of gallerists, artists, and collectors."
JP Lee, CEO of SoftBank Ventures Asia, added, "Habitus Associates Co., LTD. seamlessly integrates art with IT, revolutionizing the traditional art market. We will actively support the continued growth of Artue and, furthermore, the digital transition of the art market."
Contact Information
Ines On Sim
Communications Manager
ines@artue.io
+82-10-6298-5999
Related Files
About SoftBank Ventures Asia & Habitus Associates.docx
SOURCE: Habitus Associates Co., LTD
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/784622/softbank-ventures-asia-invests-in-habitus-associates-co-ltd-leading-the-digital-transition-of-the-art-industry
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium6.12.2024 12:30:00 CET | Press release
TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium. PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer. ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on
Accurate Background Partnering with Konfir to Provide Fast, Secure Instant Employment Verification in the United Kingdom5.12.2024 09:15:00 CET | Press release
IRVINE, CA / ACCESSWIRE / December 5, 2024 / Accurate Background, headquartered in Irvine, CA, and the largest privately held and minority-owned global provider of compliant background checks, drug and health screening, and workforce monitoring solutions, has announced a new partnership with Konfir, an innovative company providing employment verification technology in the UK. This collaboration will provide Accurate's clients access to Konfir's real-time verification tools via Accurate technology. Accurate's integration of Konfir's instant employment verification API will allow candidates to aggregate real-time data from multiple data sources including Payroll, HMRC, and Open Banking, streamlining screening processes and reducing time-to-hire. In addition, Accurate will now offer enhanced fraud mitigation tools through Konfir's suite of insights helping employers identify potential hiring risks more effectively. Kevin Stone, Sales & Marketing Director at Accurate, commented: "At Accura
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 20245.12.2024 09:10:00 CET | Press release
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion Leaders Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure Register for the event here HOUSTON, TX / ACCESSWIRE / December 5, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will host a Virtual Analyst & Investor Day on Wednesday, December 11th from 11:30 AM - 1:00 PM ET. For the event, John Climaco, Chief Executive Officer, Sandra Silberman, MD, PhD, Chief Medical Officer and Zena Muzyczenko, Vice President of Clinical Operations at CNS Pharmaceuticals will be joined by Key Opinion Leaders: Michael Weller, Prof. Dr. med. Director of Department, Department of Neurology, Universitatsspital, Zur
Atha Energy Identifies Numerous Outcrops Hosting High-Grade Uranium Mineralization5.12.2024 07:00:00 CET | Press release
HIGHLIGHTS Surficial mapping was conducted as part of the 2024 Angilak Exploration Program that focused on areas strictly proximal to the Lac 50 Deposit and achieved its objective of discovering high-grade uranium mineralization on surface beyond the extents of the Lac 50 Deposit's Exploration Target Model; High-grade surficial uranium mineralization was identified between Lac 48, Lac 50, Lac 52, and Lac 54 trends, collectively known as the Lac 50 Deposit, along prospective new parallel trends; Discovery of outlined outcrops containing high-grade uranium mineralization along strike from the Lac 50 Deposit provide basis for future exploration and significantly de-risk expansion efforts; A zone of extensive bedrock outcrop with radioactivity up to >60,000 counts per second (cps) - >10,000 cps is indicative of high-grade uranium mineralization - was identified over a 3-kilometre strike length. The new discovery is located between the Mushroom Lake zone on the Lac 52 trend and the Hot zone
TACACS.net: Strengthening Network Security with Native Active Directory Integration4.12.2024 16:55:00 CET | Press release
The Weakest Link in Cybersecurity: Addressing Authentication Vulnerabilities SAN JOSE, CA / ACCESSWIRE / December 4, 2024 / In an era where 75% of security breaches are attributed to weak authentication, the importance of robust cybersecurity measures has never been greater. Recognizing this critical need, TACACS.net has emerged as the #1 choice for Active Directory (AD) integration, offering unmatched reliability, performance, and security. Authentication is often the weakest link in network security. If a hacker cannot authenticate to a device, they cannot exploit it. TACACS.net addresses this vulnerability by delivering a solution built to meet the needs of modern organizations, ensuring fast, secure, and seamless integration with existing infrastructure. Why TACACS.net Stands Out Most organizations rely on Active Directory to manage users, but competing solutions depend on middleware-complex intermediaries that often fail, usually at the worst possible time. TACACS.net is the only
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom